ANIXA BIOSCIENCES, INC. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8dbd63ae-84df-4796-99ea-5d7440826b3a/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-10.9M | 2024-11-01 – 2025-10-31 | evidence 0001493152-26-001845 |
| FY 2024 | $-12.6M | 2023-11-01 – 2024-10-31 | evidence 0001493152-25-001787 |
| FY 2023 | $-9.8M | 2022-11-01 – 2023-10-31 | evidence 0001493152-24-002453 |
| FY 2022 | $-13.6M | 2021-11-01 – 2022-10-31 | evidence 0001493152-23-000346 |
| FY 2021 | $-13.0M | 2020-11-01 – 2021-10-31 | evidence 0001493152-23-000346 |
| FY 2020 | $-10.0M | 2019-11-01 – 2020-10-31 | evidence 0001493152-21-000456 |
| FY 2019 | $-11.6M | 2018-11-01 – 2019-10-31 | evidence 0001493152-21-000456 |
| FY 2018 | $-14.0M | 2017-11-01 – 2018-10-31 | evidence 0001513162-19-000016 |
| FY 2017 | $-5.0M | 2016-11-01 – 2017-10-31 | evidence 0001513162-19-000016 |
| FY 2016 | $-5.0M | 2015-11-01 – 2016-10-31 | evidence 0001513162-16-001101 |
| FY 2015 | $-1.4M | 2014-11-01 – 2015-10-31 | evidence 0001513162-15-000658 |
| FY 2014 | $-9.6M | 2013-11-01 – 2014-10-31 | evidence 0001513162-15-000036 |
| FY 2013 | $-10.1M | 2012-11-01 – 2013-10-31 | evidence 0001513162-14-000029 |
| FY 2012 | $-4.3M | 2011-11-01 – 2012-10-31 | evidence 0001513162-13-000088 |
| FY 2011 | $-7.4M | 2010-11-01 – 2011-10-31 | evidence 0001193125-12-029810 |
| FY 2010 | $-5.2M | 2009-11-01 – 2010-10-31 | evidence 0001193125-12-029810 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ANIXA BIOSCIENCES, INC. — all facts · Revenue · Operating Income